MAPT and Parkinson disease: In pathological studies performed to date in LRRK2-PD, variable changes have been described including Lewy bodies, tau positive inclusions, TDP-43 aggregates, ubiquitin inclusions and pure nigral cell loss with no inclusions92,93.